-transparent.png){kind=logo}
The authors developed a double in vivo crossmatch method using 2 to 3 ml of potential donor blood labeled with either 400 microCi of 99mTc or 30 microCi of 111In-oxine. Data are presented for 19 crossmatches on nine patients, using one blood specimen labeled with 99mTc or two specimens, one labeled with 99mTc and the other with 111In. Normal values are given for standardization purposes. This method appears to have advantages over earlier in vivo crossmatch techniques using 51Cr-labeled RBCs. These advantages include the rapidity with which the in vivo crossmatch may be repeated, the ready availability of 99mTc and 111In-oxine, and the lower radiation absorbed doses with the shorter-lived radionuclides.
C S Marcus, and
B A Myhre, and
M C Angulo, and
R D Salk, and
C E Essex, and
S H Demianew
January 1983,
International journal of nuclear medicine and biology,
C S Marcus, and
B A Myhre, and
M C Angulo, and
R D Salk, and
C E Essex, and
S H Demianew
June 2020,
Annales de biologie clinique,
C S Marcus, and
B A Myhre, and
M C Angulo, and
R D Salk, and
C E Essex, and
S H Demianew
March 2017,
Molecular pharmaceutics,
C S Marcus, and
B A Myhre, and
M C Angulo, and
R D Salk, and
C E Essex, and
S H Demianew
January 1989,
International journal of radiation applications and instrumentation. Part A, Applied radiation and isotopes,
C S Marcus, and
B A Myhre, and
M C Angulo, and
R D Salk, and
C E Essex, and
S H Demianew
September 1962,
Nature,
C S Marcus, and
B A Myhre, and
M C Angulo, and
R D Salk, and
C E Essex, and
S H Demianew
January 2019,
Anti-cancer agents in medicinal chemistry,
C S Marcus, and
B A Myhre, and
M C Angulo, and
R D Salk, and
C E Essex, and
S H Demianew
October 1988,
Nuclear medicine communications,
C S Marcus, and
B A Myhre, and
M C Angulo, and
R D Salk, and
C E Essex, and
S H Demianew
January 1983,
European journal of nuclear medicine,
C S Marcus, and
B A Myhre, and
M C Angulo, and
R D Salk, and
C E Essex, and
S H Demianew
October 1976,
Nuklearmedizin. Nuclear medicine,
C S Marcus, and
B A Myhre, and
M C Angulo, and
R D Salk, and
C E Essex, and
S H Demianew
June 2019,
EJNMMI research,
